Solventum Corp (fka 3M Health Care) Files 8-K

TL;DR

Solventum Corp, formerly 3M Health Care, filed its 8-K on 8/22/25.

AI Summary

Solventum Corporation, formerly 3M Health Care Co., filed an 8-K on August 22, 2025, reporting other events and financial statements. The company, incorporated in Delaware, is headquartered at 3M Center, Building 275-6W, St. Paul, MN 55144, with a principal executive office address at 3M Center, Building 275-6W, Maplewood, Minnesota 55144. The filing indicates a name change from 3M Health Care Co. to Solventum Corporation on February 3, 2023.

Why It Matters

This filing formally documents Solventum Corporation's existence and its previous identity as 3M Health Care Co., providing key corporate and address information for investors and stakeholders.

Risk Assessment

Risk Level: low — This is a routine corporate filing that primarily confirms identity and address information, with no immediate financial or operational risks indicated.

Key Numbers

• 001-41968 — SEC File Number (Identifies the company's filing with the SEC.)
• 92-2008841 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Solventum Corp (company) — Registrant
• 3M Health Care Co. (company) — Former Name
• 3M Company (company) — Associated Company (Business/Mail Address)
• August 22, 2025 (date) — Report Date
• February 3, 2023 (date) — Date of Name Change
• Delaware (jurisdiction) — State of Incorporation
• St. Paul, MN 55144 (address) — Business Address
• Maplewood, Minnesota 55144 (address) — Principal Executive Offices Address

FAQ

From the Filing

0001964738-25-000073.txt : 20250822 0001964738-25-000073.hdr.sgml : 20250822 20250822082544 ACCESSION NUMBER: 0001964738-25-000073 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250822 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250822 DATE AS OF CHANGE: 20250822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 251242264 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 solv-20250822.htm 8-K solv-20250822 FALSE 0001964738 0001964738 2025-08-22 2025-08-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 22, 2025 SOLVENTUM CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware File No. 001-41968 92-2008841 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East , Maplewood , Minnesota 55144 (Address of Principal Executive Offices) (Zip Code) (Registrant’s Telephone Number, Including Area Code) ( 651 ) 733-1110 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $.01 Per Share SOLV New York Stock Exchange Securities registered pursuant to section 12(g) of the Act: None Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company      ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act.     ☐ Item 8.01. Other Events. On August 22, 2025, Solventum Corporation (the “Company”) issued a press release announcing the commencement of cash tender offers (the “Tender Offers”) to purchase the Company’s outstanding notes of the series listed below for up to $1,750,000,000 aggregate purchase price. The Company is offering to purchase (i) its 5.450% Senior Notes due 2027 (the “2027 Notes”), 5.400% Senior Notes due 2029, 5.600% Senior Notes due 2034 and 5.450% Senior Notes due 2031 for an aggregate purchase price of up to $1,2